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significant or systematic difference between techniques for 




Conclusions: Clinically acceptable plans can be created with 
all three techniques. The use of DCA and HA appear to 
reduce planning time for spherical targets but not for 
irregular shapes. It is yet to be established if either arc-based 
technique will reduce planning and treatment times. 
HybridArc leads to significantly higher MU, which has 
implications for scatter dose. Further investigation into 
treatment times and deliverability of the planned dose 
distributions is required to determine the optimal technique. 
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Purpose/Objective: Conventional photon radiotherapy (RT) 
has successfully been applied in treatment of, both early, 
and locally advanced breast cancer. However, there are still 
concerns related to the long-term side-effects of low doses to 
nearby normal tissue, both with respect to e.g. ischemic 
heart disease (Darby et al, NEJM 2013) as well as secondary 
cancer induction in e.g. the lungs (Grantzau et al, R&O 
2014). The doses to heart and to lungs should therefore be 
kept as low as possible without compromising the target 
volume dose. The physical properties of protons make them 
attractive also for breast irradiation, however the benefit of 
protons in the context of gated treatment delivery has not 
been fully explored yet. In this study we have therefore 
compared doses to the whole heart, the left anterior 
descending coronary artery (LAD) and the left lung for left-
sided breast cancer patients treated with Deep Inspiration 
Breath Hold (DIBH) RT using either protons or photons. 
Materials and Methods: The study was performed on five 
left-sided breast cancer patients originally treated to 50 Gy 
in 2 Gy fractions, with conventional photon RT in DIBH. 
Intensity-modulated proton therapy (IMPT) plans were 
created for all the patients based on the DIBH CT-series using 
the original (breast-only) target volumes. All plans were 
initially optimized using following criteria: 95% of the 
prescribed dose to PTV, heart V25 < 5%, LAD V10 < 5% and 
lung V20 < 15%. After achieving these goals, the IMPT plans 
were optimized further in order to minimise the dose to 
organs at risk (OARs) while maintaining the 95% dose criteria 
to PTV (or D2 > 95%, i.e. at least 98% percent of the PTV 
should be covered by 95% of the prescribed dose). The mean 
dose (Dmean) for heart and LAD, the V20 for lung as well as the 
conformity index (CI=V95/PTV) were assessed.  
Results: All OAR dose/volume-parameters investigated were 
lower with IMPT compared to CRT for all five patients (Table 
1). In particular the doses to the heart and LAD were 
significantly reduced. The PTV conformity was at least 0.98 
for all IMPT plans, while it was generally lower and more 
patient-dependent for the CRT plans.  
Conclusions: For left-sided breast cancer patients treated 
with DIBH RT to the breast, the use of IMPT was found to 
yield improved PTV conformity and better sparing of heart, 
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Purpose/Objective: More than half of cancer patients 
receive radiotherapy for radical or palliative purposes. 
Increasing survival rates in cancer patients make it important 
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to study late side-effects, including secondary radiation-
induced cancers. Although a number of predictive models 
exist, the absolute accuracy of these models in the 
radiotherapy dose range is limited partly due to scarcity of 
data and partly by extrapolation beyond historical data 
bounds. One of the challenges faced with applying models to 
the highly spatially varying dose distributions produced in 
modern radiotherapy is dose heterogeneity within organs at 
risk. The aim of this work is to investigate the difference 
between using mean dose (MD) and high-resolution voxel-by-
voxel dose (VbV) maps for calculating malignant induction 
probability (MIP).  
Materials and Methods: A 3D conformal radiotherapy 
(3DCRT) and actively scanned proton plans were used for an 
adult patient and a teenage patient with medulloblastoma. 
MIP is calculated for each patient using the linear-quadratic 
(LQ), linear (LIN) and linear-no-threshold (LNT) models with 
in-house developed code. MIPs calculated using the mean 
dose to the organs as well as voxel-by-voxel dose are 
compared for individual organs and the whole body. 
Results: Whole body MIPMD for the adult patient ranged 
between 0.337 and 0.929, while MIPVbV ranged between 0.078 
and 0.929 with choice of model. MIPMD for the teenage 
patient ranged between 0.222 and 0.834, while MIPVbV ranged 




For the LNT model, where MIP is linear with dose, the MD and 
VbV results are identical, as expected. For the nonlinear LQ 
and LIN models, significant differences in MIP can be seen. 
Organ-specific MIPs vary over a wide range (Figure 1), 
although MIPMD is higher than MIPVbV by an average factor of 
1.7 (adult) and 1.6 (teenage) for both the LQ and LIN models 
for 3DCRT plans and an average factor of 3.1 (adult) and 2.3 




Use of MD gives consistently higher MIP estimates than VbV 
calculation in areas of dose heterogeneity (note reversal of 
this trend in the brain, which has a uniform high dose).  
 
Conclusions: Results demonstrate large systematic 
differences between the risk estimates produced using either 
mean dose or voxel-by-voxel calculation. Although the 
relative relation between MIPPhoton and MIPProton remains 
broadly constant, using mean dose in heterogeneous dose 
distributions potentially overestimates MIP and, by 
association, secondary cancer risk.  
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Purpose/Objective: The linear quadratic (LQ) model is the 
basis of many radiobiological predictions. Its main 
parameters α and β represent the tissues’ radiosensitivity, 
whereas the ratio α/β represents the fractionation 
sensitivity. 
Generic values are often used for biological modelling (e.g. 
α/β = 10Gy), which may not be appropriate for all tumours. 
Many studies estimate the LQ-parameters from clinical data, 
but heterogeneity in patient populations and analysis 
methods leads to disagreement between their results, 
reflected in non-overlapping 95% confidence intervals (CIs). 
Moreover, all these studies group tumours by tumour site, 
though this might not be the most predictive factor for 
tumour biology. 
The purpose of this study is to determine reliable values and 
CIs for α, β and α/β for biological modelling and explore 
factors that best explain the aforementioned heterogeneity.  
Materials and Methods: A systematic search of the Medline 
database using PubMed was performed. Papers estimating α, 
β or α/β were included if their analysis was based on clinical 
data and if none of these parameters were kept fixed in the 
analysis. 
The best statistical model for the meta-analyses of α, β and 
α/β was determined by a stepwise procedure. Different 
random effect models were compared based on the finite 
sample size Akaike Information Criterion (AICc). Next, factors 
were investigated for heterogeneity using different 
univariable models. Significant factors were then combined 
in multivariable models and the best model (lowest AICc) was 
used for the final meta-analysis. Factors that were tested 
were the type of LQ model, TCP model, clinical endpoint, 
tumour site and histology. 
Results: Out of 1059 papers returned by the systematic 
search, 60 satisfied the selection criteria, reporting 65 
estimates of α and β and 135 of α/β. The best statistical 
model for α included only the type of LQ model as factor, 
while for β and α/β the combinations LQ model + histology 
and LQ model + site provided the best (equally good) models. 
